Three RNA features have been identified that elevate retroviral transgene expression: an intron in the 5 0 untranslated region (5 0 UTR), the absence of aberrant translational start codons and the presence of the post-transcriptional regulatory element (PRE) of the woodchuck hepatitis virus in the 3 0 UTR. To include such elements into self-inactivating (SIN) vectors with potentially improved safety, we excised the strong retroviral promoter from the U3 region of the 3 0 long terminal repeat (LTR) and inserted it either downstream or upstream of the retroviral RNA packaging signal (C). The latter concept is new and allows the use of an intron in the 5 0 UTR, taking advantage of retroviral splice sites surrounding C. Three LTR and four SIN vectors were compared to address the impact of RNA elements on titer, splice regulation and transgene expression. Although titers of SIN vectors were about 20-fold lower than those of their LTR counterparts, inclusion of the PRE allowed production of more than 10 6 infectious units per ml without further vector optimizations. In comparison with state-of-the-art LTR vectors, the intron-containing SIN vectors showed greatly improved splicing. With regard to transgene expression, the intron-containing SIN vectors largely matched or even exceeded the LTR counterparts in all cell types investigated (embryonic carcinoma cells, fibroblasts, primary T cells and hematopoietic progenitor cells).
Introduction
Retroviruses and related retrotransposable elements are unique tools for the stable delivery of transgenes into target cells, because they can be inserted at defined copy numbers and without rearrangement of neighboring DNA.
1,2 Retroviral RNA is transcribed under the control of enhancer-promoter sequences that are located in the U3 region of the long terminal repeats (LTRs). This configuration is required for serial infection. However, the terminal duplication of transcriptional control regions may increase the risk of insertional activation of neighboring cellular genes, either by long-distance enhancer interactions or by providing new promoter activity from the 3 0 LTR. 1, 2 These concerns have been reinforced by the first findings of leukemic complications of retroviral transgene delivery into repopulating hematopoietic cells. [1] [2] [3] [4] [5] Enhanced safety may be achieved with self-inactivating (SIN) vectors, in which the retroviral promoter is deleted from the LTR. Instead, another viral or cellular promoter is placed internally, downstream of the RNA packaging signal (C) and thus immediately upstream of the cDNA. 6 However, despite the use of SIN vectors for more than 15 years, the impact of this design on gene expression and vector safety has not been studied in great detail. Such an investigation can only be performed if the internal promoter of the SIN vector is identical with the one used in LTR vectors.
A drawback of many SIN vectors constructed on the basis of murine leukemia viruses (MLV) or lentiviruses such as the human immunodeficiency virus (HIV) is an unfavourable configuration of untranslated regions (UTR). Thus, RNA processing may be suboptimal, leading to a substantial loss of transgene expression. Optimal RNA processing is expected to increase the safety of retroviral transgene technology, as it should reduce the danger of insertional mutagenesis by allowing the use of weaker enhancer-promoter elements and by inducing optimal splicing and termination of the transcript.
In the wild-type, LTR-controlled retroviral configuration, the 5 0 UTR contains R and U5 of the 5 0 LTR, the primer binding site (PBS), the splice donor (SD) and C. The PBS initiates minus-strand synthesis during reverse transcription. C and neighbouring elements mediate dimerization and inclusion of the proviral RNA in vector particles. As we have shown previously, the SD and C, but not the viral coding sequences, are required for efficient packaging of MLV vectors. 7 An artificial splice acceptor (SA) can be introduced downstream of C and upstream of the cDNA of interest to obtain an alternatively spliced intron in the 5 0 UTR. 7 MLVs and derived vectors generate both singly spliced and unspliced RNA. The unspliced RNA represents the genomic RNA incorporated into virions. In all replication-competent retroviruses, it also serves as the mRNA of the gag-pol gene. The env gene is expressed from a spliced message, which represents up to 50% of MLV transcripts. Vectors utilizing retroviral splice sites upstream of the cDNA of interest typically maintain this ratio of balanced splicing. [7] [8] [9] Introns in the 5 0 UTR are found in many cellular genes, improving transcriptional elongation and nuclear export of RNA. 10, 11 In some retroviruses, constitutive RNA export elements have been identified within the viral coding sequences that facilitate the expression of unspliced RNA. [12] [13] [14] For MLVs, the sequences regulating alternative splicing and mediating nuclear export of unspliced RNA are unknown. 12, 14 Incomplete splicing may be due to a slightly degenerated splice acceptor consensus upstream of env. Moreover, the first 28 nucleotides of the R region form a stem loop (RSL) that supports the cytoplasmic accumulation of unspliced MLV RNA. 15 To promote correct translation of the unspliced retroviral transcript, we have previously removed aberrant translational start codons, 7 which are present in the majority of retroviral vectors used so far in clinical applications. 4, 16, 17 RNA export and translation of retroviral vectors may also be improved when incorporating the post-transcriptional regulatory element (PRE) of the woodchuck hepatitis virus into the 3 0 UTR. This PRE promotes retroviral RNA expression in many but not all cell types, 9, 18, 19 in part by linking RNA to the CRM-1-dependent nuclear export pathway that is typically used for protein export but also exploited by the Revdependent export of HIV. 20 In the present study, we developed a series of SIN and LTR vectors with identical promoters and found that the LTR configuration is superior for achieving high titers but not required for strong transgene expression. Introducing a novel vector design, we demonstrate that SIN vectors can be constructed with a favorable intron in the 5 0 UTR, that these vectors show improved RNA splicing compared to LTR vectors, and that the inclusion of the PRE increases the titer of these vectors to levels that allow the transduction of primary hematopoietic cells without further concentration procedures.
Results

Construction of retroviral vectors
All retroviral vectors used in this study lacked viral coding sequences and aberrant translational start codons that potentially interfere with the function of the inserted sequences. The modular vector assembly allowed precise exchanges of cis-active elements. All constructs carried identical enhancer-promoter sequences from the U3 region of spleen focus-forming virus (SFFVp), which we have shown to be a good choice for driving high levels of transgene expression in hematopoietic cells. 21 The activity of the SFFVp enhancer-promoter is excellent in fibroblasts and hematopoietic cells, followed by T-lymphocytes, and is strongly reduced in primitive embryonic cells. 22 The 5 0 UTR originates from the murine embryonic stem cell virus and contains a PBS that does not suppress LTR-mediated transcription in primitive, multipotent cells such as embryonic carcinoma (EC) cells, a feature that may also be relevant for some multipotent stem cells of adult tissues. 21, 23 All vectors used in the present study expressed the enhanced green fluorescent protein (EGFP) from the position of the retroviral gag gene, thus mimicking the wild-type configuration of the retroviral 5 0 UTR. 7 Three versions of LTR vectors were compared, 9 either lacking both intron and PRE (SF110), or containing an intron in the 5 0 UTR (SF91), or containing an intron in the 5 0 UTR plus the PRE in the 3 0 UTR (SF91P) (Figure 1a ). Corresponding SIN vectors with similar RNA modules and an identical retroviral enhancer-promoter were generated by deleting the entire enhancer-promoter contained in the U3 region of the plasmid's 3 0 LTR, leaving just the first 22 bp (upstream of enhancer) and the last 14 bp (downstream of TATA box) of the U3 region. To be used for internal initiation of transcription, the same retroviral enhancer-promoter fragment plus the last 14 bp of U3 and the adjacent RSL (designated as U3r fragment) was placed into internal positions of the SIN (Figure 1b ).
Retroviral transduction of target cells
Retroviral vector plasmids were transiently transfected into Phoenix-gp packaging cells for the production of replication-defective vector stocks, using cotransfected plasmids encoding either ecotropic, gibbon ape leukemia virus (GALV) or vesicular stomatitis virus (VSV) envelope glycoproteins. 24, 25 The vectors were first evaluated in murine SC1 fibroblasts, HT1080 human fibrosarcoma cells, EL4 mouse lymphoma cells and F9 mouse EC cells. Target cells were transduced with a defined multiplicity of infection (MOI) to obtain equal transgene dosage, largely limited to one copy per cell. This is important, as we have demonstrated in previous work a clear increase of transgene expression level and clonal variability of gene expression when introducing more than one copy into target cells. 24, 25 Protein expression was determined by flow cytometry of EGFP fluorescence in single cells of unselected polyclonal mass cultures.
Cell type dependence of LTR vector expression
In all SIN vectors except SinSF, the retroviral enhancerpromoter was placed a short distance downstream of the PBS, to maintain the highest degree of similarity with the 5 0 UTR of an LTR-controlled vector. To compare LTR driven with internal initiation of transcription, we started with vectors lacking RNA control elements such as splice sites or the PRE. When comparing SF110 and SinSF110, fibroblasts showed a significantly increased expression of the LTR configuration (about 50-100% higher activity of SF110 in SC1 and HT1080 cells). In contrast, the corresponding SinSF110 vector with the internal promoter was slightly superior in F9 EC cells (ratio SF110/ SinSF110 ¼ 0.7, P ¼ 0.13, Table 1 ). The reduced activity of LTR vectors in F9 cells would be compatible with earlier observations that linked attenuation and shut-off of retroviral gene expression in primitive embryonic cells to the presence of tissue-specific repressor elements in the retroviral enhancer. 23, 26 The better performance of the LTR configuration in 'permissive' cells such as SC1 or HT1080 may as well be explained by the terminal duplication of the retroviral enhancer. These data indicated that the duplication of the enhancer-promoter in the LTR (and the deletion of these sequences from the LTR in SIN vectors) has a cell-type-dependent impact on the transcriptional potency of retroviral vectors. Therefore, subsequent investigations involved a series of different cell types, with a stronger emphasis on somatic cells that are more relevant for human gene therapy than EC cells.
Splicing to improve SIN vector performance: psintron vector concept
To determine the optimal configuration of the 5 0 UTR, several configurations of SIN vectors were compared. The absence of C from the 5 0 UTR (vector SinSF, Figure  1b ) doubled the expression levels (Po 0.05), irrespective of the cell type investigated ( Table 1 , ratio SinSF/ SinSF110). The unspliced C region present in SinSF110 may thus inhibit retroviral RNA export and/or translation, possibly as a result of its complex secondary structure.
We next investigated whether encompassing C by splice signals would improve the performance of SIN vectors. Taking advantage of the necessity for C in retroviral replication would select full-length transgenes containing the intron in particle formation. 7 For biosafety reasons, this concept appears to be superior to the proposed use of cytoplasmic RNA viruses in the production of intron-containing retroviral vectors. 27 Consequently, we placed the U3r fragment downstream of the PBS and thus outside the LTR, but upstream of the SD and C (vector SinSF91, Figure 1b ). This region is the only reasonable target for promoter insertion when attempting to generate SIN vectors containing a retroviral intron. However, it was unclear as to whether this region would tolerate the insertion of larger sequences, especially when considering the highly conserved primary and secondary structure of the retroviral leader region. The 5 0 UTR was terminated by a minimal retroviral SA mediating balanced splicing in LTR-controlled vectors. 7 The novel design for SIN vectors with C within the intron was named psintron (vectors SinSF91 and SinSF91P, Figure 1b) .
In retroviral packaging cells, genomic RNA of psintron vectors is driven from the MLV enhancer-promoter located in the plasmid's 5 0 LTR. Interestingly, despite the potential for promoter competition with the neighboring internal MLV promoter, the psintron design allowed the production of infectious vector particles with useful titers (although not as efficiently as the LTR Table 1 Influence of promoter position, absence of C in the 5 0 UTR and the retroviral intron on transgene expression
Promoter in LTR or 3 0 of PBS SF110/SinSF110 0.8 1.0 1.4* 1.9* Absence of C in 5 0 UTR SinSF/SinSF110 1.9* 2.4* 1.9* 1.8* Splicing of C in SIN vectors SinSF91/SinSF110 2.8* 4.6* 2.9* 2.9* Calculations based on mean values of at least four (up to 37) independent determinations per construct for F9, SC1 and HT1080, and three determinations for EL4 cells. Standard deviations were o20%. *P-valueo0.05 (Student's t-test, two-sided).
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vectors, see below). The absence of U5 (containing the attachment sites for the retroviral integrase) and PBS (strictly required for reverse transcription) from the internal psintron transcript guaranteed that these vectors cannot be mobilized following the first round of retroviral transduction. Accordingly, retroviral packaging cells transduced with psintron vectors did not produce infectious particles (data not shown).
To address the impact of the retroviral intron on EGFP expression, the mean green fluorescence of unselected mass cultures transduced with SinSF91 was determined by flow cytometry. The SinSF110 vector lacking splice sites served as a control (same MOI). It should be noted that the EGFP coding sequences are not dependent on splicing for mRNA export, while some cellular sequences such as b-globin are. 9 With EGFP, splicing significantly increased expression by a factor of 2.8 (F9 cells) to almost 5 (EL4 cells, Table 1 , ratio SinSF91/ SinSF110). Splicing of the retroviral intron was confirmed by Northern blot and RT-PCR analysis (below). Taken together, these data provide proof of concept for the design of MLV-based SIN vectors with a functional intron in the 5 0 UTR. These data are in line with our findings using LTR vectors, in which splicing increases EGFP expression up to five-fold both in cell lines and in primary hematopoietic cells 7, 9 (and data not shown). Thus, LTR vectors containing the engineered intron used here have been demonstrated to express several transgenes in primary hematopoietic and lymphoid cells to potentially therapeutic levels.
28-31
Differentiation dependence of the PRE
Inclusion of the PRE in the 3
0 UTR (vector SinSF91P, Figure 1 ) further elevated EGFP levels in cell lines (Btwo-to three-fold, Figure 2a (Figure 2a ). According to green fluorescence, SinSF91P was four times stronger than the conventional SIN vector (SinSF, Po0.05). The histograms demonstrated that EGFP expression mediated by either SF91P or SinSF91P was well above background levels in both cell types (F9 and SC1), with a similar variability between independent unselected cells ( Figure 2b ). The FACS histograms also indicated that retroviral vector expression was generally attenuated in F9 cells compared with SC1 cells, in line with earlier findings. 23, 26 Both in F9 cells and in fibroblasts, SinSF91P even showed slightly higher activity than the corresponding LTR vector (SF91P), although this did not reach statistical significance. Nevertheless, this stands in contrast to the results achieved with SIN vectors lacking RNA processing modules (ratio SF110/SinSF110, Table 1 ).
However, in an independent study we have observed that the PRE reduced rather than increased the expression of SIN vectors in primary hematopoietic cells. 19 These results were achieved with vectors in which the PRE was introduced 3 0 of the EGFP cDNA in the SinSF backbone (which lacks an intron). 19 We obtained similar results when comparing the LTR vectors SF91 and SF91P in primary murine hematopoietic cells (Figure 2c ). The cells were transduced with identical MOI of both vectors, resulting in the transduction of o15% of target cells (range 1-14%). After transduction, cells were cultured for RNA processing of SIN vectors J Kraunus et al 8 days in vitro. Combining the data of four experiments, we observed a B50% reduction of transgene expression in the presence of the PRE (Po0.05 for all lineages at day 8). Under these conditions, the attenuating effect of the PRE in primary hematopoietic cells was independent of the differentiation status (Figure 2c ). Nevertheless, we preferred to introduce the PRE in MLV SIN vectors, because we observed a striking effect on the yield of infectious particles produced in retroviral packaging cells.
PRE is important for high titers of psintron vectors
An important practical aspect of viral vectors is the titer of replication-defective particles harvested from safetymodified packaging cells. To obtain infectious retroviral particles, vector transcripts starting with the R region of the 5 0 LTR and maintaining C must be generated from the plasmid's 5 0 LTR promoter in the transfected packaging cells. However, transcripts originating in packaging cells from the internal U3r promoter are not able to generate infectious virus, due to the lack of essential motifs (such as U5 and PBS) located between +33 and +182 of the retroviral 5 0 UTR. For identical plasmids, titers of cell-free retroviral vector stocks harvested after independent transfections of packaging cells were highly reproducible, but they varied strikingly with respect to vector design (Figure 3 ). Titers were determined by limiting dilution infection of constant numbers of target cells (SC1) and flow cytometric analyses of transduction frequencies 3 days after vector exposure. When producing ecotropic particles, the best LTR vector (SF91P) generated more than 5 Â 10 7 transducing units per ml cell-free supernatant. Psintron vectors (SinSF91, SinSF91P) had at least 20-fold lower titers than their LTR counterparts (SF91 and SF91P, respectively). In psintron vectors SinSF91 and SinSF91P and the splice-defective control SinSF110, the internal U3r promoter inserted between PBS and SD is expected to compete with the upstream positioned 5 0 LTR promoter of the plasmid, thus lowering infectious titers (see Discussion for alternative hypotheses).
Interestingly, the presence of splice sites surrounding the C region increased rather than decreased infectious titers, confirming our earlier data obtained with LTR vectors. 7 This result may be independent of splicing, possibly due to improved folding of the wild-type leader and/or more stringent interaction with gag nucleocapsid domains.
The PRE improved titers with a much stronger effect in the SIN configuration (10 Â increase) than in the LTR context (2 Â increase). The comparison of the psintron vector (SinSF91) with the conventional SIN vector (SinSF) revealed that the insertion of the promoter between PBS and SD reduced the output of infectious particles 5-to 10-fold (Figure 3 ). Still, a reasonable yield (above 10 6 particles/ml) was achieved with psintron vectors when introducing the PRE (SinSF91P).
We also tested whether introducing the PRE into the residual U3 region of the psintron vector (instead of upstream of the residual 3 0 LTR) would result in a better expression. However, vector titers were suboptimal (average yield 1.5 Â 10 6 /ml versus 3 Â 10 6 /ml with SinSF91P), and the expression levels were also slightly reduced compared with SinSF91P (range 85-95%, n ¼ 7, SC1 fibroblasts).
Finally, we used real-time PCR to determine the transgene copy number in SC1 cells transduced with an MOI of up to 0.3, using either SF91P or its SIN counterpart, SinSF91P. The real-time PCR showed very similar threshold cycles for both vectors (SF91P: 30.870.2; SinSF91P: 30.370.1), indicating that the reduced titers of the psintron vector could not be explained by an increased rate of silencing.
In summary, the PRE was required to produce sufficient titers of the psintron vectors, thus avoiding the need of particle concentration when targeting primary cells. It should be noted that, despite the significant differences in vector yields, all expression analyses described here were performed using normalized titers, ruling out the possibility that results were caused by different gene dosages.
24,25
Improved splicing of the retroviral intron in psintron vectors
To investigate to what extent EGFP expression levels were dependent on RNA expression levels and splicing, total cellular RNA was prepared from sorted but uncloned populations of SC1 cells transduced with the vectors of interest and analyzed in Northern blots. No splicing of the constructs was observed in the absence of the retroviral splice sites (Figure 4a, lanes 2, 3 and 6) . Similar results were obtained by RT-PCR using RNA from transduced EL-4 cells (Figure 4b) .
A surprising and important finding of these experiments was that vectors containing an identical retroviral intron (SD-C-SA) but different sequences upstream of SD differed with respect to the expression of unspliced RNA. Complete splicing of the intron was observed in SinSF91 (psintron), as opposed to balanced splicing in the LTR-driven vector, SF91 (Figure 4a 
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J Kraunus et al versus SinSF110, Figure 4c ) than with the LTR vectors (SF91 versus SF110, Figure 4c ). As described above, the major sequence difference between the 5 0 UTRs of SF91 (alternative splicing with equimolar transcript ratio) and SinSF91 (complete splicing) was the absence of nucleotides located between +33 and +182 in the latter. RNAs of both vectors contained the RSL sequence, previously found to be required for the accumulation of unspliced RNA. 15 Our data therefore suggest that the RSL region cooperates with sequences located between +33 and +182, either to promote export of the unspliced transcript or to impede splicing of the retroviral transcript. Moreover, the quantification of the hybridization signals revealed that the presence of C reduced overall RNA levels (compare SinSF and SinSF110, Figure 4c ). Taken together, these data indicate previously unknown functions of retroviral leader elements in RNA splicing and export. The precise nature of the sequences and mechanisms involved is subject of an ongoing investigation.
Improved protein expression of SIN vectors
RNA levels and EGFP fluorescence were generally in good agreement within the series of SIN vectors ( Figure  4c ). In contrast, all LTR vectors (SF110, SF91, SF91P) showed a relatively lower EGFP expression per RNA, which was likely due to insufficient expression and/or export of unspliced LTR transcripts. In line with this hypothesis, presence of the PRE partially compensated the less efficient protein expression of LTR vectors. These data showed that although LTR vectors tend to produce more RNA, protein expression levels achieved with psintron vectors were at least equivalent. We conclude that a reduced (in comparison with LTR vectors) transcriptional activity of SIN vectors can be compensated by improved RNA processing.
The vector-dependent differences in protein expression levels observed with the sorted mass cultures (Figure 4c ) were similar to those of unsorted cells ( Figure  2a ). It appears safe to conclude from the above findings that psintron vectors are capable of mediating similar expression levels as their LTR counterparts while simultaneously reducing the load of potentially 'dangerous' enhancer sequences by 50% and completely avoiding the presence of a promoter in the 3 0 LTR.
Expression of SinSF91P in primary hematopoietic and lymphoid cells
To demonstrate the utility of psintron vectors for gene transfer into primary hematopoietic cells, we transduced murine bone marrow cells using unconcentrated Vector RNA levels were quantified using a phoshpoimager and normalized for the b-actin RNA load. EGFP levels were derived from the mean fluorescence intensity measured by flow cytometry. Data obtained with the SinSF vector were set to 1.
RNA processing of SIN vectors J Kraunus et al supernatants and cultured cells for 8 days post-transduction. As in all other experiments described above, we compared SF91P and SinSF91P with low MOIs to achieve polyclonal mass cultures with gene expression frequencies below 30%. This results in single copy insertions in the majority of EGFP+ cells, as shown in detail in our earlier studies. 24, 25, 32 SinSF91P almost matched the expression level of SF91P in primary murine hematopoietic cells, irrespective of the differentiation status of the cells (Figure 5a and b) .
Ecotropic supernatants were also used to transduce primary murine T cells. The average transduction efficiency was 20% for SF91P (n ¼ 2) and 14% for SinSF91P (n ¼ 4). Cells were analyzed for 8 days in culture, showing strong expression of both vectors (Figure 5c ). Interestingly, SinSF91P tended to mediate higher (B30%) transgene expression than SF91P (Figure  5d ). For the transduction of human primary T cells derived from peripheral blood leukocytes, particles pseudotyped with the envelope protein of GALV were produced. The titer of the SinSF91P vector did not exceed 
Discussion
This study introduces a novel configuration of introncontaining SIN retroviral vectors with promising expression features in embryonic and somatic cells and potentially increased biosafety. We also show for the first time that foreign sequences can be inserted between the PBS and the retroviral SD, opening further perspectives for the development of retroviral (including lentiviral) vectors.
We started with the observation that SIN vectors with internal MLV promoters showed better expression than corresponding LTR vectors in undifferentiated EC cells, but not in fibroblasts. An intact LTR probably increases the susceptibility to cell-type-specific transcriptional activators and repressors by duplicating the retroviral target sequences. The likelihood of attracting activators may thus be increased in differentiated cells, but not in undifferentiated EC cells that lack key regulators of the retroviral enhancer such as AML1/PEBP. 33, 34 Likewise, the LTR configuration may increase the susceptibility to transcriptional repressors in EC cells, which express several negative regulators of MLV transcription. 23, 26 Superior persistence of gene expression in differentiating embryonic stem cells has been demonstrated for lentiviral vectors with an internal promoter in comparison to retroviral LTR vectors. [35] [36] [37] Our data, in line with previous observations of Stewart et al, 38 suggest a hypothesis that improved performance in primitive embryonic cells is mainly dependent on the use of an appropriate promoter in an internal position of a retroviral vector. 
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To increase the potential of SIN vectors, we focused on the improvement of RNA processing. This approach may be as relevant for both biosafety and efficiency as the inclusion of chromatin modulating elements, 39 because improved RNA processing reduces the need for strong enhancers. We have shown that an intron in the 5 0 UTR provides a robust increase in transgene expression, while the PRE acts in a more differentiation-dependent manner. The PRE thus even decreased transgene expression in primary hematopoietic cells, at least in the context of the vectors studied here that express high levels of transcript in these cells. Similarly, the PRE has been found to reduce expression in primary hematopoietic cells when used in MLV SIN vectors that did not contain an intron. 19 This may indicate a relative deficiency of cellular cofactors such as CRM-1 which seem to be required for PRE activity. 20 In packaging cells and nonhematopoietic target cells studied here, the PRE enhanced transgene expression. Given the requirement of the PRE to obtain high-titer supernatants of MLV SIN vectors and its relatively mild attenuation of transgene expression in primary hematopoietic cells, we would recommend the inclusion of this element in MLV SIN vectors. The preferred position appears to be upstream of the 3 0 SIN LTR, but inclusion into the SIN LTR also worked without a substantial loss of activity.
Our study establishes that an intron can be introduced in SIN vectors when placing the promoter in a novel position upstream of the SD and thus a short distance downstream of the PBS. The presence of C within the intron guaranteed its transfer to target cells. HIV vectors may be able to transfer intron-containing transgenes, possibly due to splice inhibitory features of the Rev/RRE interaction occurring in packaging cells. 40 However, the frequency of intron loss has not been carefully investigated. The MLV vector technology lacks such a conditional splice inhibitory mechanism. The psintron strategy compensates this deficiency and may be more reliable than the Rev/RRE interaction in transducing the intron to target cells. The psintron concept is therefore also of interest for the construction of lentiviral vectors, especially when their packaging process is rendered Rev independent. 41 The expression of SIN vectors was enhanced by the intron in the 5 0 UTR, which could be explained by the positive feedback of splicing factors with transcriptional elongation and the improved nuclear export of spliced RNA. 10, 11 The psintron architecture should be of particular interest when attempting to express cDNAs such as b-globin, which are even more dependent on splicing for nuclear export. 9 A welcome consequence of the psintron design was the virtually complete splicing of the retroviral intron. This may prevent interaction of the retroviral SD with downstream splice acceptor sequences of cellular genes and thus further reduce the mutagenic potential of random vector insertions. Improved splicing also elevates expression and may thus allow the use of weaker promoters without loss of efficiency. Somewhat surprisingly, improved splicing occurred in our constructs despite the use of retroviral splice consensus motifs, which are considered to be suboptimal. 12, 14 Our study thus points to the presence of yet unknown retroviral RNA processing signals, which may either have a splice inhibitory activity or promote the nuclear export of unspliced retroviral RNA. As indicated by our ongoing experiments, these sequences are likely located upstream of the position in which we introduced the promoter of psintron vectors (in the region comprising the 3 0 half of R, the complete U5, the PBS and 17 bp 3 0 of the PBS). While SIN (including psintron) vectors offer valuable safety features and should be suitable to incorporate promoters for inducible or differentiation-specific expression, their major disadvantage is related to vector production. Cloned producer cells with high titers for clinical scale vector production are not easily obtained with such a vector configuration. Several reasons may have contributed to the reduced yield of infectious particles with the vectors developed in the present study: (i) the known negative effect of U3 deletions on the titer of MLV vectors, 6 a problem not encountered with HIV-derived vectors; 40 (ii) promoter interference 42 between the 5 0 LTR and the nearby located internal promoter of psintron vectors, leading to reduced expression of genomic RNA in transfected packaging cells; (iii) interference of the internal U3r with the functions of neighboring domains of C or PBS; and (iv) suboptimal processing during later steps of reverse transcription. Considering that titer optimization was not the focus of the present study, the results obtained with the first generation of psintron vectors were encouraging, in particular, with the use of the PRE (SinSF91P). Of note, both titers and expression levels were higher than those achieved with the intronless 'conventional' SIN vector, SinSF. This allowed a reasonable transduction efficiency in primary hematopoietic cells without the need for concentrating vector supernatants.
Finally, it remains to be tested whether the SIN configuration of MLV vectors affects termination and polyadenylation of the retroviral RNA, as previously described for HIV-based SIN vectors. 43 Since by far the most frequent mechanism for insertional proto-oncogene activation is long-distance enhancer interaction, 44 the reduction of enhancer load in the SIN configuration already promises a major step towards increased safety. This may be further enhanced when incorporating weaker enhancer-promoter elements than the one used here, given that therapeutic levels of transgene expression can still be achieved.
In addition to the implications for retroviral vector expression and safety, our observation that the small space between the PBS and the SD can accommodate foreign sequences extends the flexibility in the design of retroviral (including lentiviral) vectors. In an LTRcontrolled backbone, this position could be used to introduce a coding sequence or a transcriptional enhancer. In SIN vectors, this position may be used for insertion of any type of chromatin-organizing domain (such as matrix attachment region, insulator, enhancer), recognition sites for sequence-specific recombinases or possibly even complete transgene cassettes (including a promoter). Fine-tuning of the distance to the PBS and the SD may result in further improved vector performance.
Materials and methods
Plasmids
Vector plasmids pSF110, pSF91 and pSF91P were constructed using the modular assembly described RNA processing of SIN vectors J Kraunus et al earlier. 9 A SalI restriction site was introduced at position +179 (relative to the cap site) of the retroviral untranslated leader region by PCR (primer leaSal+ 5 0 -GGAG ACCCCTGCCCGTCGACCACCGACCCCCCCG-3 0 , mutating bases underlined), to allow insertion of foreign sequences. For the construction of the SIN vectors, the plasmids 3 0 LTR was deleted using two PCR products. The first was generated using oligonucleotide U3NheI (5 0 -ATCGCTAGCGGTGGGGTCTTTCATTCCCCCCT-3 0 ) and M13forward (5 0 -TGACCGGCAGCAAAATG-3 0 ), and cleaved with BamHI, cutting after the EGFP cDNA. The second product was obtained using primers U3EcoRI (5 0 -ATCGAATTCACAACCCCTCACTCGGCGCGCCA-3 0 ) and M13reverse (5 0 -GGAAACAGCTATGACCATG-3 0 ), and cleaved with XhoI, cutting after the end of the 3 0 LTR. Ligation of the cleaved PCR products generated an EcoRV site between NheI and EcoRI, all corresponding to the primer sequences. Thus, only the first 22 bp and last 14 bp of the U3 region were left, excluding the entire enhancer/promoter. The U3-RSL fragment was amplified and tailed with novel restriction sites using primers XhoEagSF65 (5 0 -CTCGAGCGGCCGCTAGCTGCAGTA ACGC-3 0 ) and SalEagSF63 (5 0 -GTCGACCGGCCGACTC AGTCAATCGG-3 0 ). For insertion into the NotI site located downstream of C, EagI was used, resulting in pSinSF. For insertion into the SalI site located between the PBS and the SD, the product was cut using XhoI and SalI, resulting in pSinSF110. By exchanging the sequences between SalI and NotI, a defined leader fragment distinguished by the presence of splice sites was introduced, resulting in plasmid pSinSF91. The PRE element was obtained from plasmid pSF91EGFP-gPRE, 9 and introduced either downstream of EGFP (plasmid pSinSF91P) or into the SIN LTR (plasmid pSinSF91P2) after a partial digest with EcoRI. All PCRs for cloning were performed using proofreading Pfx polymerase (Invitrogen, Karlsruhe, Germany) in combination with Taq polymerase (Qiagen, Hilden, Germany).
Cells and transfections
Phoenix-gp packaging cells and human HT1080 fibrosarcoma cells were grown in Dulbecco's modified Eagle medium, mouse SC1 fibroblasts (ATCC # CRL-1404), and mouse F9 EC cells (ATCC # CRL-1720) in minimal essential medium, mouse EL4 lymphoma cells (ATCC # TIB-39) in RPMI. The media were supplemented with 10% FCS, 2 mM glutamine, 1 mM sodium pyruvate and with 100 U/ml penicillin/streptomycin. The day before transfection of Phoenix-gp cells, 45 5 Â 10 6 cells were plated in a 9 cm plate. For transfection, the medium was exchanged and 25 Â mM chloroquine (Sigma) was added. Retroviral vector DNA (6 mg) was transfected using the calcium phosphate precipitation method. To generate VSV-G pseudotyped particles, 10 mg M57 (MLV gag/pol expression plasmid) and 2 mg M75 (VSV-G expression plasmid) were transfected in addition. For the generation of ecotropic or GALV-pseudotyped particles, an expression vector for the ecotropic envelope protein or the GALV glycoprotein, respectively, was used instead of M75. 46, 47 The medium was exchanged after 6-12 h. In some experiments, equal transfection efficiency was controlled by flow cytometry of transfected cells. Supernatants containing the viral particles were collected 24-84 h after transfection, filtered through a 0.22 mm filter and used to transduce 1 Â 10 5 target cells. Transduction was assisted by adding 4 mg/ml protamine sulfate and centrifugation for 60 min at 400 g and 25-321C. Vector titers were determined by transducing predefined numbers of SC1 or HT1080 target cells with serial dilutions of supernatant and analyzing the percentage of positive cells by flow cytometry. Further analysis was limited to those experiments where less than 30% of target cells were productively transduced. After transduction, cells were grown for another 2-3 days before analysis. Sorted populations of EGFP-expressing cells were grown for at least 5 weeks before analysis.
Primary hematopoietic cells and lymphocytes
Bone marrow cells from C57Bl/6 mice were collected from femurs and tibias and suspended in IMDM plus 10% FCS. Lineage marker negative cells were enriched using the mouse lineage panel (BD Pharmingen, Heidelberg, Germany) and MACS column (Miltenyi, BergischGladbach, Germany) separation following the manufacturer's instructions, as described. 48 The flow through fraction (LinÀ) was cultured in IMDM supplemented with 20% FCS, 2 mM glutamine, 100 U/ml penicillin/ streptomycin, 50 ng/ml mSCF, 100 mg/ml hFLT3L, 100 ng/ml hIL11 and 20 ng/ml mIL3. 48 At the third day of culture, cells were transduced with cell-free retroviral particles at an MOI of 1. 48 Flow cytometry was performed one and 8 days after gene transfer using lineage antibodies (BD Pharmingen) as indicated in Results.
Human mononuclear blood cells were isolated at day 1 from healthy donor buffy coats by centrifugation (900 g; 20 min) on a Ficoll gradient (Biochrom, Berlin, Germany). T-lymphocytes were activated (using anti-CD3 and anti-CD28 antibodies) and cultured in X-Vivo10 containing 8% autologous serum (in the presence of 300 U/ml IL-2) essentially as described. 49 The first transduction was carried with the five vectors SF91, SF91P, SinSF91, SinSF91P and, for control, SF11EGFPrev 24 and with noninfectious supernatant (mock control) in the morning of day 4 using our centrifugation protocol. 49 A second infection cycle was performed in the evening of the same day for the low titer constructs SinSF91 and SinSF91P. All procedures were repeated on day 5. On day 6, only SinSF91 and SinSF91P were used for repeated transduction cycles. Overall, we performed six transduction cycles with the low-titer and 2 with the high-titer constructs. All cells were kept at 371C and 5% CO 2 in a humidified atmosphere. Transduction efficiency and transgene expression were measured in the evening of day 8, on days 11 and 15 on a FACScan instrument using CellQuest software (Becton Dickinson, San Jose, CA, USA).
Flow cytometry
At least 10 6 cells were harvested and washed in PBS. To determine the expression of the EGFP transgene, cells were analyzed in a FACScalibur (Becton Dickinson, Heidelberg, Germany) using CellQuest software (Becton Dickinson). In the analysis of immortalized cells, a gate was set on a homogeneous cell population, as determined by scatter characteristics. A marker was set to calculate the percentage and mean fluorescence intensity of positive cells. Mass cultures of EGFP-expressing F9 or SC1 cells were sorted using a MoFlo instrument (Cytomation, Freiburg, Germany).
Northern blot and RT-PCR
Total RNA preparation was performed using the RNA Instapure reagent (Eurogentec, Brussels, Belgium). For Northern blot, 15 mg of each RNA were separated at 2 V/ cm in 1% agarose gels, after denaturing RNA samples with glyoxal and DMSO. Subsequently RNAs were transferred onto Biodyne B membrane (0.45 mm, Pall) by capillary transfer and UV crosslinked (Stratalinker, Stratagene). Specific probes used for hybridization corresponded to the cDNAs of EGFP or chicken b-actin. Probes (25 ng) were radiolabeled using the Prime it II kit (Stratagene) to an activity of at least 10 6 cpm/ml hybridization solution and separated from unincorporated nucleotides on spin columns. Filters were washed, sealed and exposed to X-ray films (Kodak X-omat-AR) or quantified by phosphoimager (Fuji, Dü sseldorf, Germany) analysis. RNAs of transduced, unsorted EL4 cells were reverse transcribed using Superscript II RT (Gibco BRL, Karlsruhe, Germany) and oligo(dT)15 primer (Boehringer Mannheim, Germany). Specific products were obtained by PCR using primers SD5-1 (5 0 -CCG TATTCCCAATAAAGCCT-3 0 ) and EGFPreverse (5 0 -GGT CAGCTTGCCGTAGGTGGC-3 0 ).
Real-time PCR
Genomic DNA was purified using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). Quantitative real-time PCR was performed using the QuantiTect SYBR Green PCR Kit (Qiagen) and the iCycler real-time PCR detection system (Bio-Rad Laboratories, Muenchen, Germany) according to the manufacturer's instructions. Primers 5 0 GFP RT (TATATCATGGCCCGACAAGCA) and 3 0 GFP RT (ACTGGGTGCTCAGGTAGTG) amplified a 162 bp EGFP DNA fragment. 19 DNA samples were measured in triplicate.
